South Bend, IN, United States of America

Marvin J Miller

This inventor holds 42 USPTO granted patents and 10 published patent applications, plus 5 CIPO patents and 5 EPO patents, primarily in Antibacterial Compounds. Top assignees: University of Notre Dame Du Lac, Azevan Pharmaceuticals, Inc., Hsiri Therapeutics, Inc.. Active years: 1986-2026.

USPTO Granted Patents = 42 (Patent Applications = 10)

% Patents Active = 92.9

CIPO Patents = 5 (Patent Applications = 2)

EPO Patents = 5 (Patent Applications = 11)

Average Co-Inventor Count = 2.0

ph-index = 7

Forward Citations = 152(Granted Patents)

Location History:

Mishiwaka, IN (US) (2012 - 2014)
Notre Dame, IN (US) (2017)
South Bend, IN (US) (1986 - 2023)

Company Filing History:

36 out of 387

University of Notre Dame Du Lac

patents

5 out of 12

Azevan Pharmaceuticals, Inc.

patents

1 out of 1

Hsiri Therapeutics, Inc.

patent

4. 1 out of 4

Klinikum Der Universitat Munchen

patents

5. 1 out of 2

Leibniz-Institut Für Naturstoff-Forschung Und Infektionsbiologie E.v. -Hans-Knöll-Institut- (Hki)

patents

where one patent can have more than one assignee

Years Active: 1986-2026

Loading Chart...

Areas of Expertise:

Antibiotic Conjugates

Biosensors

Antibacterial Monobactams

Deuterated Antimicrobial Compounds

Sideromycins

Beta-Lactams

Heterocyclic Compounds

Antimycobacterial Agents

Nucleosides

Cancer Compounds

Azetidinones

Cyclization Processes

42 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12544384 - Antibiotic conjugates (2026-02-10),

2. 12379376 - Biosensor and method for detection of analytes (2025-08-05),

3. 11820767 - Benzyl amine-containing heterocyclic compounds and compositions useful against mycobacterial infection (2023-11-21),

4. 11731947 - Deuterated antimicrobial compounds (2023-08-22),

5. 11400079 - Antibacterial monobactams (2022-08-02),

6. 11155542 - Antimicrobial compounds, their use for the treatment of mammalian infections and a new metabolic mechanism (2021-10-26),

7. 11149046 - Antibacterial sideromycins (2021-10-19),

8. 11014891 - Reduction-triggered antibacterial sideromycins (2021-05-25),

9. 10919888 - Benzyl amine-containing heterocyclic compounds and compositions useful against mycobacterial infection (2021-02-16),

10. 10913737 - Imidazo [1,2-a]pyridine compounds, synthesis thereof, and methods of using same (2021-02-09),

11. 9908876 - Imidazo [1,2-a]pyridine compounds, synthesis thereof, and methods of using same (2018-03-06),

12. 9862680 - Peripherally substituted monocyclic beta-lactams (2018-01-09),

13. 9708339 - 1,3-benzothiazinone, sulfoxide, and sulfone compounds with electrophilic substituent (2017-07-18),

14. 9617249 - Benzoheterocyclic anti-bacterial agents (2017-04-11),

15. 9605002 - 5,5-heteroaromatic anti-infective compounds (2017-03-28),

Title: The Innovative Journey of Marvin J Miller

Introduction: Marvin J Miller, a talented inventor hailing from South Bend, IN, has made significant contributions to the world of technology through his groundbreaking innovations.

Latest Patents: Marvin J Miller's latest patents showcase his prowess in developing cutting-edge solutions for various industries, ranging from healthcare to automotive.

Career Highlights: Throughout his illustrious career, Marvin J Miller has been recognized for his inventive spirit and problem-solving skills, leading to the successful development of numerous patented technologies that have revolutionized their respective fields.

Collaborations: Marvin J Miller has collaborated with leading research institutions, universities, and companies to bring his innovative ideas to life, fostering a culture of creativity and forward thinking in the industry.

Conclusion: Marvin J Miller's dedication to innovation and his passion for creating impactful solutions have solidified his reputation as a pioneering inventor in the realm of technology.